Navigation Links
BioInformatics, LLC Offers Solutions for Optimizing Service and/or Maintenance Contracts
Date:8/13/2008

ARLINGTON, Va., Aug. 13 /PRNewswire/ -- According to new research from BioInformatics, LLC (http://www.gene2drug.com) -- the leading market research and consulting firm serving the life science industry -- service providers in the life science industry must innovate to find new ways to demonstrate customer value. As offerings become more diverse, including multi-vendor, original equipment manufacturer (OEM), in-house and a combination of all three, vendors must respond to customers' increasing demand for choices. In its latest report, "Instrumentation Service Contracts: Opportunities for Differentiation," BioInformatics, LLC explores optimal ways to balance risk, quality and costs of service and/or maintenance contracts.

"Navigating the complex terrain of service and/or maintenance contracts poses new challenges for life science suppliers," observed Tamara Zemlo, Ph.D., Director of Syndicated Research and Analysis at BioInformatics. "Instruments have become more sophisticated and customers are more demanding." According to Dr. Zemlo, structuring contracts in a way that responds to the unique needs of each client is the key to winning in this increasingly competitive landscape.

This report provides an in-depth market overview and competitive analysis of the most common types of contracts offered in the life sciences market. While almost one-half of maintenance and/or service contracts are with the OEM, customers are more frequently turning to alternative suppliers. According to the life scientists surveyed for this report, in addition to dependability, customers expect personalized service and maximum flexibility as well.

The report has a number of significant findings for scientific and lab equipment suppliers. 49% of maintenance and/or service contracts are for a single-year duration. 36% of scientists who are disappointed with service would give contract providers a second chance and request a contract extension. 41% of respondents are highly interested in consolidating maintenance and/or service contracts with a single OEM. This invaluable report provides suppliers with a roadmap for differentiating service offerings in order to build customer loyalty and charge premium prices.

While customer preferences have been measured independent of specific vendors, profiles for five major OEM's -- Agilent Technologies, Applied Biosystems, Beckman Coulter, Bio-Rad Laboratories and GE Healthcare were studied as well. Significant differences by market segment are also highlighted in this report.

"The vendor-client relationship necessarily includes understanding customer preferences, pro-actively increasing positive touchpoints and educating customers as to how a particular service offering is unique," Dr. Zemlo noted. "Instrumentation Service Contracts: Opportunities for Differentiation" provides suppliers with insights from over 500 life scientists with regard to all of these strategic areas. Plan to attend a free webinar to discuss ways to optimize service and/or maintenance contracts on Tuesday, September 9 at 1pm EDT. To register for your seat at the webinar, email m.follin@gene2drug.com. For a complimentary Executive Summary of this report, please visit http://www.gene2drug.com/report/195/ .

ABOUT BIOINFORMATICS, LLC

BioInformatics, LLC is the premier research and advisory firm serving the life science industry. By leveraging our professional social network of more than 36,000 biomedical researchers, we have supported more than 300 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

For more information, please contact:

Mary Follin

Director of Communications

BioInformatics, LLC

2111 Wilson Blvd., Suite 250

Arlington, VA 22201

703.778.3080 x13 (phone)

mfollin@gene2drug.com

http://www.gene2drug.com/


'/>"/>
SOURCE BioInformatics, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Sigma-Aldrich Recognized by BioInformatics, LLC as Having the Most Useful and Easiest to Use Online and Print Catalogs
2. BioInformatics, LLC Studies Trade Show Exhibition Strategies in the Life Science Market
3. SCAN Health Plan Offers Seniors Five Tips to Prepare for Surgery
4. REvolution Computing Offers Hands-On Tutorial of NWS Parallel Computing Environment at BioC 2008
5. Facelift for Resumes Offers Hope for Job Seekers, says Resume Writing Service
6. Online Career Tool Offers Live Expert Advice Component
7. TCN e-Systems Offers Trial Sponsors Solutions for Creating In-House Center of Excellence in Patient Recruitment
8. LMXonline Offers Spanish-Language Safety and Health Training Library
9. ARR Offers Parents Extended Choice in Egg Donor Selections
10. Genetic Testing for All: QTrait Offers Industrys Least Expensive, Most Secure DNA Tests With TRUSTe Certification
11. New TUMS(R) QuikPak(TM) Campaign Offers Innovative Heartburn Relief with a Little Help from the Jetsons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Surgical Wound Market with the addition of its newest module, US Hemostats & ... market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
(Date:10/11/2017)... BioMarketing, a leading provider of patient support solutions, has announced ... network, which will launch this week. The VMS CNEs will ... to enhance the patient care experience by delivering peer-to-peer education ... professionals to help women who have been diagnosed and are ... ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
Breaking Biology Technology:
(Date:8/23/2017)... ARMONK, N.Y. , Aug. 23, 2017  The general public,s help ... the human microbiome—the bacteria that live in and on the human body ... ... bacteria in the human microbiome, starting with the gut. The project's goal ... in disease. Photo credit: IBM ...
(Date:6/23/2017)... and ITHACA, N.Y. , ... and Cornell University, a leader in dairy research, today ... bioinformatics designed to help reduce the chances that the ... the onset of this dairy project, Cornell University has ... for Sequencing the Food Supply Chain, a food safety ...
(Date:5/16/2017)... , May 16, 2017   Bridge ... health organizations, and MD EMR Systems , ... development partner for GE, have established a partnership ... Portal product and the GE Centricity™ products, including ... EMR. These new integrations will ...
Breaking Biology News(10 mins):